In breast cancer surgery, does a positive basal (deep) margin or a close (≤1 mm) negative basal margin indicate the need for adjuvant radiotherapy?

Basal Margin Status and Adjuvant Radiotherapy in Breast Cancer

A positive basal (deep) margin—defined as ink on invasive cancer or DCIS—mandates either re-excision or adjuvant radiotherapy, as it is associated with a two-fold increase in ipsilateral breast tumor recurrence (IBTR) that is not nullified by radiation therapy alone. 1

Understanding Positive Margins

The definition of a positive margin is critical and unambiguous:

• Positive margin = ink on tumor cells (invasive cancer or DCIS at the inked specimen surface) 1
• This applies to all margins including the basal (deep) margin when tumor extends to the inked edge 1
• A positive basal margin represents potentially incomplete resection with significantly elevated recurrence risk 1

Evidence for Increased Recurrence Risk

The magnitude of risk with positive margins is substantial and consistent:

• Positive margins confer an odds ratio of 2.44 for IBTR (95% CI, 1.97-3.03) compared to negative margins 1
• This two-fold increased risk persists despite adjuvant radiation boost (OR 2.45, p<0.001) 1
• Systemic therapy does not eliminate this risk: OR remains 2.53 (p<0.001) even with endocrine therapy 1
• Even favorable tumor biology (ER-positive) does not negate the risk (OR 2.66, p<0.001) 1
• The 10-year IBTR rate ranges from 14-16% with positive margins versus 6-9% with negative margins 1

Management Algorithm for Positive Basal Margins

When a positive basal margin is identified:

1. Re-excision is the preferred approach to achieve negative margins before radiation therapy 1

   • This minimizes long-term IBTR risk, particularly in patients not receiving systemic therapy 1
   • Re-excision should be performed even if other margins are negative 1

2. If re-excision is not feasible (due to anatomic constraints at the pectoral fascia):

   • Adjuvant radiotherapy is mandatory but provides only partial risk mitigation 1
   • Even with radiation boost, absolute IBTR risk remains unacceptably high at 17.5% (95% CI, 10.4-24.6%) 1
   • Consider conversion to mastectomy if cosmetic outcome would be poor or patient has extensive disease 1

Close But Negative Basal Margins

Close margins (<2mm but not touching ink) do NOT require re-excision in invasive breast cancer:

• The SSO-ASTRO consensus guideline establishes "no ink on tumor" as the standard for negative margins 1
• Wider margin widths beyond "no ink on tumor" do not significantly reduce IBTR risk 1
• Routine re-excision for close margins is not indicated and represents a common clinical error 2

Exception for DCIS component:

• When DCIS is present (pure DCIS or invasive cancer with DCIS), margins must be ≥2mm 1
• Margins <2mm in DCIS are associated with significantly increased ipsilateral recurrence 1, 2
• This is a critical distinction from invasive cancer alone 1

Critical Pitfalls to Avoid

Common errors in margin management:

• Performing re-excision for close (<2mm) but negative basal margins in invasive cancer without DCIS 2
• Assuming radiation therapy adequately compensates for positive margins—it does not 1
• Failing to distinguish between invasive cancer (no ink on tumor sufficient) and DCIS (≥2mm required) 1, 2
• Not considering the presence of extensive intraductal component (EIC), which increases recurrence risk with positive margins from 10% to 42% 1

Special Considerations

Factors that increase the significance of positive basal margins:

• Extensive intraductal component (EIC): 42% recurrence rate with positive margins versus 0% with negative margins 1
• Diffuse margin involvement (>3 low-power fields): 28% recurrence rate versus 9% for focal involvement 1
• Morpheaform/infiltrative histology: Higher risk of incomplete excision and recurrence 1

The basal margin warrants particular attention as it often abuts the pectoral fascia, and re-excision may be technically challenging but remains the gold standard when tumor extends to ink 1